comparemela.com

Latest Breaking News On - Regulationst rule - Page 6 : comparemela.com

TAT Technologies : Reports First Quarter 2024 Results - Form 6-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 F O R M 6-K .

Israel
Gedera
Hamerkaz
Piedmont
Washington
United-states
Sigal-zamir
Technologies-ltd
Nasdaq
Equity-fund
Principal-executive-office
Securities-exchange-commission

TAKEDA PHARMACEUTICAL : Form 6-K - MarketScreener

Document FORM 6-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

Washington
United-states
Tokyo
Japan
Osaka
Chuo-ku
Norimasa-takeda
Securities-exchange
Commission-file-number
Tokyo-stock-exchange
Foreign-private-issuer
Securities-exchange-act

ChipMOS TECHNOLOGIES : Clarification of Taiwan media report - Form 6-K

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 .

Republic-of-china
Taiwan-general
Taiwan
Washington
United-states
Securities-exchange
Commission-file-number
File-number
Name-into-english
Hsinchu-science-park
Principal-executive-offices

Vision Marine Technologies : Changes in Registrant's Certifying Accountant - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER.

Canada
Washington
United-states
Canadian
Raffi-sossoyan
Commission-file-no
Departure-of-independent-registered-public-accounting-firm
Vision-marine-technologies-inc
Ernst-young
Exchange-commission
Securities-exchange
Company-annual-reports-on-form

AstraZeneca : plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore - Form 6-K

a0072p FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

Singapore
Washington
United-states
Cambridge
Cambridgeshire
United-kingdom
Pascal-soriot
Adrian-kemp
Commission-file-number
Astrazeneca
Company-on-social-media-astrazeneca
Company-secretary

vimarsana © 2020. All Rights Reserved.